Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.
BioNano's Bumpy Road:One company that has been a great investment in the past two years has been biotech stockBioNano Genomics Inc(NASDAQ:BNGO).
BioNano's key technology is its Saphyr System, a cytogenetic testing device that detects structural deficiencies within a cell's nucleus. The system then uses genome mapping for disease diagnosis.
While the FDA has not approved...
ログインすると全部閲覧できます。
ログイン